Navigation Links
AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy Platform
Date:9/17/2008

AMSTERDAM, The Netherlands, September 18 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license from Amgen to use their GDNF gene for the development of a gene therapy treatment for Parkinson's disease. The combination of this gene with AMT's proprietary adeno-associated virus (AAV) gene therapy platform could potentially allow the development of an effective, long-term treatment for this progressive and crippling disease.

Parkinson's disease is the second most common neurodegenerative disease. It usually affects people over 65 with an estimated total of 4.5 million patients worldwide. Due to increasing life expectancy of the general population, the number of patients with Parkinson's disease is expected to double to around 9 million patients between now and the year 2030.

Patients with Parkinson's disease slowly lose control of their muscles, resulting in tremors, stiffness, slowness of movement, and lack of coordination and thus in a serious loss of quality of life. Parkinson's is caused by degeneration and death of nerve cells in a specific part of the brain. These cells produce dopamine, a substance necessary for communication between nerve cells involved in the coordination of movement. Current therapies are limited to treatment of symptoms. There are no therapies available that slow down or halt the progression of the disease.

A new way to deliver the GDNF gene

"This license from Amgen offers us a unique opportunity to combine our gene technology and know-how with the GDNF gene as a tool to create a potential breakthrough in the treatment for this common and severely debilitating disease," said Ronald Lorijn, CEO of AMT "We believe our gene therapy approach could be an effective way to deliver the gene to the regions of the brain affected by Parkinson's disease."

Protect and improve nerve cells with GDNF


'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
2. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
3. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
4. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
5. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
6. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
7. Duke Licenses ALPHADAS(R), Logos Technologies EDC System to Accelerate its Early Phase Clinical Trials
8. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
9. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
10. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
11. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 /PRNewswire-iReach/ -- "Spain Aesthetic Lasers ... key market data on the Spain Aesthetic Lasers ... in millions of US dollars, volume (in units) ... segments Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) ... (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power ...
(Date:9/15/2014)... Sept. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... wholly owned subsidiary, Valeant Pharmaceuticals International, will redeem all ... its 6.75% Senior Notes due 2017, CUSIP Nos. 91911XAL8, ... and has mailed an irrevocable notice of redemption for ... copy of the irrevocable notice of redemption with respect ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- MedicOne Medical Response, ... services, has been selected by Inc. Magazine as ... America. Photo - http://photos.prnewswire.com/prnh/20140914/145997 ... list identifies successful, privately-held companies with the largest ... Response, one of only two ambulance companies to ...
Breaking Medicine Technology:Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3
(Date:9/16/2014)... is the event of the year for the latest ... of the Acute Cardiovascular Care Association (ACCA) of the ... October in Geneva, Switzerland. , Monday 16 September ... the specialty of cardiology dealing with acute problems in ... and acute heart failure. The scientific programme is available ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 According ... Market Research "Latin America Home Healthcare Market (By ... Healthcare Devices, Mobility Assist Devices and Medical Supplies; ... Infusion Therapy and Unskilled Home Healthcare Services) - ... 2014 - 2020" the Latin American Home Healthcare ...
(Date:9/16/2014)... VA (PRWEB) September 16, 2014 Norfolk, ... of delectable gluten-free and allergy friendly desserts, announced today ... for Breast Cancer Awareness Month this October. In support ... eliminating cancer, Lucy’s® will provide a charitable donation in ... one of the most common cancers among women in ...
(Date:9/16/2014)... HealthDay Reporter , MONDAY, Sept. 15, ... face a higher risk of developing an aggressive type of ... suggests. But, the study authors noted that it,s not ... should be concerned. Their study only found an association between ... prove cause and effect. "It is conceivable that, in ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Current students ... the Capstone Event in Yelm, Washington, Oct. 20-26 to ... the year and caps off the remarkable “Masters of ... world in Switzerland, Italy, Australia, South Korea, Mexico, and ... half price for children ages 6-19 and for seniors ...
Breaking Medicine News(10 mins):Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 2Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 2Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 3Health News:Male Pattern Baldness Tied to Prostate Cancer, Study Suggests 2Health News:Male Pattern Baldness Tied to Prostate Cancer, Study Suggests 3Health News:Ramtha School Presents Capstone Event in Yelm Oct. 20-26 2
... extensively drug-resistant tuberculosis (XDR TB) in the United States, ... and difficult-to-treat disease between 1993 and 2006, and 77 ... The study appears in the August 15 issue of ... California reports almost 3,000 cases of tuberculosis annually, the ...
... benefits are weighed , , WEDNESDAY, Aug. 13 (HealthDay ... suggests. , Would-be participants in an extramarital affair tend ... researchers from the University of New Hampshire (UNH) and ... the decision differ slightly between men and women, said ...
... Network Growing, BUFFALO, N.Y., Aug. 13 ... national, electronic healthcare network,and has announced the ... healthcare providers., (Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NYW083LOGO ... Medina Memorial Health Care,System, and MedFirst Urgent ...
... and Two Rivers among Thomson ... MILWAUKEE, Aug. 13 Three Aurora Health Care facilities,are ... having,demonstrated the fastest, most consistent improvement over five consecutive,years., ... Medical Center of,Green Bay were ranked in the Thomson ...
... a,lazy Sunday with a great meal and relaxing spa treatments. Voda ... Sunday, from 12pm - 4pm, Voda Spa offers the taste and ... Brunch Massage $140 Brunch Scrub ... Choose from a selection of delicious dishes from our restaurant. All,brunches ...
... LAKE OSWEGO, Ore., Aug. 13 West Coast ... of LifeWorks Northwest, a,leading non-profit, community-based mental health ... pledge and a corporate gift. The donation,will sponsor ... Children and Youth Recreation Fund., Additionally, West ...
Cached Medicine News:Health News:Extensively drug-resistant tuberculosis found in California 2Health News:Men and Women Calculate Cost of Affairs 2Health News:Wolfson's HealthTransaction Network(R) Signs Four New Hospital Systems 2Health News:Three Aurora Hospitals Named Top Performers in National Thomson Reuters Annual Survey 2Health News:Three Aurora Hospitals Named Top Performers in National Thomson Reuters Annual Survey 3Health News:West Coast Bank Sponsors LifeWorks Northwest Programs for Children in Low-Income Housing Communities 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: